Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: A team of 20 doctors, including surgeons, neurosurgeons, anesthesiologists and nurses, will be deployed to the region of Marche in central Italy for two weeks, Italian ambassador to Ukraine, Davide La Cecilia told Reuters. “The national health service in our country is very stressed. So we badly need medical personnel and are very happy that Ukraine is sending this humanitarian aid,” said La Cecilia at Kiev’s airport, before the medical mission’s departure. Ukrainian Interior Minister Arsen Avakov, who accompanied the ambassador, said Kiev would send more medical aid and disinfectant to Italy in the coming days. “It is an honour for us to help Italy during such tough times. We know that many Ukrainians live and work in Italy. By helping Italy, we are helping our citizens,” said Avakov. Ukraine’s health ministry has reported 1,096 cases, including 28 deaths since March 3, when the first case was recorded. But as thousands of Ukrainians have recently returned home from abroad, the ministry expects a much bigger outbreak ahead. The daily tally of new cases increased to 154 on Saturday from 138 on Friday, up from 62 last Monday. The head of the Ukrainian medical mission, neurosurgeon Andriy Miroshnichenko, said that all the team members volunteered to work in Italy. “After they come back home, they will be able to treat patients and work having practical experience and knowledge about the disease,” said Miroshnichenko. Asked whether the Ukrainian doctors were not afraid to catch the virus themselves Glib Bidyukov, a nurse, said it was “a consciously made choice”. “When you choose healthcare, you understand that you put yourself in some danger… Each of us made a choice a long time ago,” Bidyukov said.
[EX A]: Ukrainian doctors fly to Italy to help combat coronavirus.

[EX Q]: We were surprised to see that a story that covered as much ground as this one did somehow missed costs. The competing story by NBC spelled out the costs. The story nicely explained that while one of the new studies showed, as expected, that following the updated statin guidelines did increase the number of people who would be treated with statins, following the guidelines would apparently not have saved a significant number of people from dying or having a heart attack or stroke. The story said, “Among the people eligible for statins under the old guidelines, 6.9 percent had a heart attack or stroke or died from coronary disease over the ensuing nine years. Among those eligible for statins under the new guidelines, the figure was 6.3 percent, almost as high. That suggests that the new guidelines do not lead to treatment of many more people who do not need statins.” At the same time, the story noted that the new guidelines “over all did a better job in discriminating between those who should and should not get statins.” It said that “only 1 percent of participants deemed ineligible for statins under the new guidelines had a heart attack or stroke over nine years, compared with 2.4 percent of those ineligible under the old guidelines.” While an NBC story also used absolute numbers in talking about the potential benefits in terms of heart attacks, we liked the greater level of context provided in the Times piece. Nevertheless, we think it would have been useful for the Times to include the Number Needed to Treat in its discussion of benefits —  this is an easy-to-understand metric that was reported in the study. In addition, we question the Times’s contention that the new criteria “do not lead to treatment of many more people who do not need statins.” According to the study, approximately 94% of both guideline groups did not have a cardiovascular event, and yet the new criteria now extend the use of statins to much larger number of people. In light of such findings, it’s unclear that the new criteria don’t lead to unnecessary treatment for more people as the Time states. We wish the story had explored this result more thoroughly. We thought that NBC did a better job detailing some of the potential harms from statin use, but we give the Times credit here for framing the story as a discussion of risks vs. benefits and making it clear that experts critical of the new guidelines believe that they “would lead millions of additional people to take statins, exposing them to potential side effects such as muscle pain or damage with little to gain.” Covering two studies in little more than 1,000 words is already a feat. Doing so while bringing in enough context to explain the caveats to the study is an order of magnitude greater. Compared to the NBC piece, the Times did a superior job showing that, despite the enthusiasm in some quarters of the scientific community, the two studies did not settle the debate over whether statins should be more widely prescribed. The story did not engage in disease mongering. The story sought out and made good use of independent sources. It mentions that the guidelines were widely criticized and links to some printed criticisms made at the time. It quotes a variety of supportive and critical researchers regarding their opinions on the new research. The story did not make any reference to dietary changes, lifestyle changes, or exercise. The story made it clear that statins are widely prescribed. One in four Americans take them by some estimates. The story established that the findings of the studies were not novel but rather were in keeping with earlier findings about statins. Because it contains comments from independent experts, we can be sure the story did not rely excessively on any news release.
[EX A]: 2 Studies Back Guidelines for Wider Use of Statins

[EX Q]: A bill that would allow trained pharmacists to administer the influenza vaccine to children 12 years and older cleared the General Assembly’s Public Health Committee in a 17-7 vote this year, but it later died on the Senate calendar due to inaction. Bill supporter, Nathan Tinker, CEO of the Connecticut Pharmacists Association, said his organization doesn’t plan to push hard for it again in the next regular legislative session because he is worried the debate over the General Assembly’s efforts to scrap a religious exemption for some vaccines will ultimately spill over into discussions about the flu shot and likely doom the bill in the short, three-month session. “There is a community of people who are concerned about the impact or potential impact, whether real or perceived, about vaccines,” Tinker said. “And they get a lot of attention from legislators and that can make it difficult.” When the new legislative session opens in February, lawmakers are expected to consider ending the state’s longstanding religious exemption after newly released data showed a continued decline in immunization rates for measles, mumps and rubella among kindergarteners. That proposal has already met resistance and some of the concerns raised are like the ones voiced during this year’s discussion of the flu vaccine bill. Legislators were flooded with testimony earlier this year from parents with concerns about whether making the vaccine more convenient could lead to injuries that pharmacists might not be trained recognize. Others questioned the motives of the pharmaceutical industry and necessity of flu shots. Dr. Sandra Carbonari, a primary care pediatrician in Waterbury and the medical director of the Connecticut Chapter of the American Academy of Pediatrics, also opposed the bill, but for different reasons. She questioned whether state regulations for providing the flu vaccine to children who receive Medicaid benefits might ultimately make the shot too expensive, and whether DPH’s vaccine program can handle a large increase in the number of providers. She also noted that immunizing a child can be complicated. “Determining the appropriate vaccine for a pediatric age patient is not simple and requires accurate information about the medical history and current state of health,” she said in written testimony. Supporters of the flu shot bill argue that allowing parents to drop by a pharmacy, rather than make an appointment with a pediatrician, would ultimately lead to higher flu immunization rates. The bill had the support of the state’s Department of Public Health, which noted three children in Connecticut died from flu-related complications during the 2017-18 flu season. Pharmacists in Connecticut are currently allowed to vaccinate people 18 years or older. According to DPH, individuals under 18 can be administered the flu vaccine by advanced practice registered nurses at retail locations, such as a CVS MinuteClinic. Sen. Heather Somers, of Groton, the top Senate Republican on the Public Health Committee who co-sponsored this year’s bill, stressed that the legislation is voluntary and requires the consent of a parent or guardian. Somers contends the legislature just ran out of time to act on the bill earlier this year, and she plans to resurrect it when lawmakers convene again in February for the 2020 session. “This is something that saves lives,” said Somers, who helped to organize a mobile flu clinic in her district last year. “I think accessibility is key in our health care system.”
[EX A]:
Bill allowing pharmacists to give kids the flu shot at risk.